Defective Heparin lawsuits, a blood thinner manufactured by Baxter Healthcare, will finally go on trial in November, 2010. The recalled batches of Heparin killed at least 81 people according to the FDA from late 2007 to early 2008, and they caused injuries and sickness to hundreds more. The drugs caused severe allergic reactions because one of the component ingredients was replaced by over-sulfated chondroitin sulfate. That ingredient mimics the properties of Heparin. It was obtained by Baxter from a Chinese supplier, and that supplier’s facilities were determined to be deficient by the FDA. Furthermore, evidence obtained in discovery indicates that the chondroitin sulfate was intentionally used as a cheaper alternative, despite the life-threatening injuries it can cause.
The Heparin lawsuits are consolidated in an MDL in the U.S. District Court for the Northern District of Ohio, and case selection will start around May of 2010.